EssilorLuxottica (OTCMKTS:ESLOY) Shares Gap Down – Time to Sell?

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) gapped down before the market opened on Monday . The stock had previously closed at $141.21, but opened at $128.88. EssilorLuxottica shares last traded at $129.4350, with a volume of 25,850 shares trading hands.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Zacks Research cut shares of EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 18th. Citigroup reiterated a “buy” rating on shares of EssilorLuxottica in a report on Thursday, December 11th. Kepler Capital Markets upgraded shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Thursday, January 15th. HSBC upgraded EssilorLuxottica from a “hold” rating to a “buy” rating in a research report on Wednesday, January 14th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating on shares of EssilorLuxottica in a research note on Friday, December 5th. Two research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Buy”.

EssilorLuxottica Stock Down 1.4%

The company has a current ratio of 0.97, a quick ratio of 0.67 and a debt-to-equity ratio of 0.18. The stock’s fifty day moving average is $152.35 and its two-hundred day moving average is $162.63.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.